Di Giacomo, Anna Maria
Covre, Alessia
Giacobini, Gianluca
Ibrahim, Ramy
Lyman, Jaclyn
Natali, Pier Giorgio
Maio, Michele
Funding for this research was provided by:
Associazione Italiana per la Ricerca sul Cancro (IG 2014 ID 15373, IG 06/30/C/9)
Article History
Received: 24 July 2018
Accepted: 11 December 2018
First Online: 18 December 2018
Compliance with ethical standards
:
: Anna Maria Di Giacomo served on the advisory board of Bristol-Myers Squibb, Incyte, Pierre Fabre, Glaxo Smith Kline and she is a member of the scientific board of directors of the NIBIT Foundation; Ramy Ibrahim is a member of the scientific advisory board of: Arcus, Harpoon, Immunovaccine and ImaginAB;Jaclyn Lyman is a PICI employee; Pier Giorgio Natali is a member of the scientific board of directors of the NIBIT Foundation; Michele Maio served on advisory boards of Bristol-Myers Squibb, Roche-Genentech, Merck Sharp Dohme and AstraZeneca-MedImmune, and he is the president of the NIBIT Foundation. The authors declare that there are no other conflicts of interest.